SARS-CoV-2感染对早产、出生体重及产科并发症风险的影响:一项基于全国人群的回顾性队列研究的多变量分析
该研究基于法国全国数据库,纳入2020年3月至12月所有单胎分娩共510387例,其中2927例(0.6%)母亲和/或新生儿确诊COVID-19。分析显示COVID-19与妊娠期高血压、子痫前期、糖尿病及剖宫产风险升高相关, logistic回归显示COVID-19与早产的校正比值比为1.77(95%CI 1.55-2.01),与巨大儿无显著关联。结论认为COVID-19是早产的危险因素。
要点
- COVID-19组妊娠期高血压、子痫前期、糖尿病及剖宫产率均高于非COVID-19组(p<0.01)。
- COVID-19组28-31周及32-36周早产率均高于非COVID-19组(p<0.01),小于胎龄儿无显著差异。
- 校正后COVID-19与早产的aOR为1.77(95%CI 1.55-2.01),与巨大儿的aOR为1.38(95%CI 0.95-2.00)未达显著。
核心结论
- COVID-19是早产的危险因素,即使校正其他危险因素后仍存在关联。
研究设计与样本
- 法国全国性、基于人群的回顾性队列研究,数据来自国家医疗信息系统数据库。
- 纳入2020年3月至12月所有单胎分娩510387例,其中2927例(0.6%)母亲和/或新生儿确诊COVID-19。
主要发现
- COVID-19组与非COVID-19组比较:妊娠期高血压2.8% vs 2.0%(p<0.01),子痫前期3.6% vs 2.0%(p<0.01),糖尿病18.8% vs 14.4%(p<0.01),剖宫产26.8% vs 19.7%(p<0.01)。
- COVID-19组与非COVID-19组比较:28-31周早产1.3% vs 0.6%(p<0.01),32-36周早产7.7% vs 4.3%(p<0.01),巨大儿1.0% vs 0.7%(p=0.04),小于胎龄儿6.3% vs 8.7%(p=0.15,无显著差异)。
- 早产的多因素logistic回归:COVID-19的校正比值比(aOR)为1.77(95%CI 1.55-2.01)。
- 巨大儿的多因素logistic回归:COVID-19的aOR为1.38(95%CI 0.95-2.00),未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of maternal coronavirus disease 2019 (COVID-19) on prematurity, birthweight and obstetric complications. DESIGN: Nationwide, population-based retrospective cohort study. SETTING: National Programme de Médicalisation des Systèmes d'Information database in France. POPULATION: All single births from March to December 2020: 510 387 deliveries, including 2927 (0.6%) with confirmed COVID-19 in the mother and/or the newborn. METHODS: The group with COVID-19 was compared with the group without COVID-19 using the chi-square test or Fisher's exact test, and the Student's t test or Mann-Whitney U test. Logistic regressions were used to study the effect of COVID-19 on the risk of prematurity or macrosomia (birthweight ≥4500 g). MAIN OUTCOME MEASURES: Prematurity less than 37, less than 28, 28-31, or 32-36 weeks of gestation; birthweight; obstetric complications. RESULTS: In singleton pregnancies, COVID-19 was associated with obstetric complications such as hypertension (2.8% versus 2.0%, p < 0.01), pre-eclampsia (3.6% versus 2.0%, p < 0.01), diabetes (18.8% versus 14.4%, p < 0.01) and caesarean delivery (26.8% versus 19.7%, p < 0.01). Among pregnant women with COVID-19, there was more prematurity between 28 and 31 weeks of gestation (1.3% versus 0.6%, p < 0.01) and between 32 and 36 weeks of gestation (7.7% versus 4.3%, p < 0.01), and more macrosomia (1.0% versus 0.7%, p = 0.04), but there was no difference in small-for-gestational-age newborns (6.3% versus 8.7%, p = 0.15). Logistic regression analysis for prematurity showed an adjusted odds ratio (aOR) of 1.77 (95% CI 1.55-2.01) for COVID-19. For macrosomia, COVID-19 resulted in non-significant aOR of 1.38 (95% CI 0.95-2.00). CONCLUSIONS: COVID-19 is a risk factor for prematurity, even after adjustment for other risk factors. TWEETABLE ABSTRACT: The risk of prematurity is twice as high in women with COVID-19 after adjustment for factors usually associated with prematurity.
引用
- Simon E, Gouyon JB, Cottenet J, et al. Impact of SARS-CoV-2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population-based retrospective cohort study. BJOG. 2022. PMID: 35253329. doi:10.1111/1471-0528.17135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。